INNOVADERM CRO IS NOW INDERO.

Podcast

FILTER BY:

Innovaderm to Indero
Podcast

Episode 41: Ekaterina Radchenko – Eurekas from EULAR 2026: Rheumatology’s Euro-bonanza!

Innovaderm to Indero
Podcast

Episode 40: Diane Leclerc – Leading from the Ground Up: Strategy, Transition, and Team Accountability

Innovaderm to Indero
Podcast

Episode 39: Esther Sanchez – Building a Robust Startup Unit in Clinical Trials

Innovaderm to Indero
Podcast

Episode 38: Raelle Kennedy (Woke Within Skin) – Eczema, Equity, and Empowerment

Innovaderm to Indero
Podcast

Episode 37: Simon Grant (Ascilion) & ThĂ©o Boyer – ISF: A New Dimension in Skin Biomarkers

Innovaderm to Indero
Podcast

Episode 36: Siow Bee Seu – Clinical Trials Across Asia Pacific

Innovaderm to Indero
Podcast

Episode 35: PTCA – Speaking the Same Language: How Patient Organizations and Sponsors Can Align in Clinical Trials

Innovaderm to Indero
Podcast

Episode 34: Isabel Dorion – Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact

Innovaderm to Indero
Podcast

Episode 33: Ana Palijan – Beyond Safety: The Evolving Complexity of Early Phase Studies

Innovaderm to Indero
Podcast

Episode 32: Sarah Ballard – Strategic Storytelling: The Role of PR in Biotech & Pharma Stakeholder Engagement

Innovaderm to Indero
Podcast

Episode 31: Ted Trafford and Brad Hightower – Dos and Don’ts for Sponsors and CROs in Site Collaborations – Part 3: Payments

Innovaderm to Indero
Podcast

Episode 30: Ted Trafford and Brad Hightower – Dos and Don’ts for Sponsors and CROs in Site Collaborations – Part 2: Focus on Protocol

Subscribe to our Podcast.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.